Ballicules.com

Propylthiouracil

PTU

What it isThionamide inhibiting thyroid peroxidase and peripheral thyroid-hormone activation; hyperthyroidism.

Why this oneIts peripheral conversion block makes it useful in thyroid storm, and it is preferred early in pregnancy.

What limits itSevere liver failure keeps it second-line otherwise; agranulocytosis demands urgent evaluation of fever or sore throat.

FDA-approved for

FDA label

BOXED WARNING Severe liver injury and acute liver failure (some fatal, some requiring transplant) reported in adults and children; reserve for patients who cannot tolerate methimazole and in whom radioactive iodine or surgery are not appropriate.
FDA dosingPopulationStartTargetMax
HyperthyroidismAdults300 mg/day divided q8h (TID)maintenance 100–150 mg/day400 mg/day usual; occasionally 600–900 mg/day initially (severe)
HyperthyroidismPediatric ≥6y (rare; only when alternatives inappropriate)50 mg/day, titrate upward

Renal Undefined

Hepatic Undefined

Instructions

Cautions

Adverse reactions

Pregnancy May be the preferred antithyroid agent during or just before the first trimester (methimazole teratogenicity); crosses placenta and can cause fetal goiter/cretinism — use lowest effective dose; given maternal hepatotoxicity risk, consider switching to methimazole for 2nd/3rd trimesters.

Lactation Undefined

⚠ BOXED WARNING

Cost, est. cash$10–$300/month

Generic entry2023

Classes and tags

Clinical profile

Therapeutic safety burden4 / 4
Overdose danger2 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk1 / 4

Legacy pregnancy categoryUnknown / historical label unavailable

Defining liabilityPotentially fatal hepatic failure and agranulocytosis; generally reserved for selected situations.

Mechanism of action: Propylthiouracil ballicule

Propylthiouracil ballicule: receptor binding, kinetics and half-life diagram

Open Propylthiouracil in the interactive console ↗